Sleep Apnea Devices Market by Device Type, Companies, Forecast

According to the latest report by Renub Research, titled “Sleep Apnea Devices Market, Global Forecast, Impact of COVID-19, Industry Trends by Device Type, Opportunity Company Overview, Revenue” the Sleep Apnea Devices Market is expected to reach US$ 8.7 Billion by 2027. Sleep apnea is a disorder distinguished by rhythmic and repetitive obstruction of the upper airway provoking pharyngeal collapse. During sleep apnea disorder, breathing is repeatedly interrupted during sleep; these breathing pauses typically last between 10 to 20 seconds and happen from 5 to over 100 times per hour. There are three main characters of sleep apnea obstructive sleep apnea, central sleep apnea, and complex sleep apnea syndrome. Sleep apnea therapy aims to open the airway and breathe better at night. Many devices help that happen.

Key Market Trends:

  • The expanding prevalence of (OSA) obstructive sleep apnea disorder, complex sleep apnea syndrome and central sleep apnea are among the key factors driving the growth of the Sleep apnea device industry. Such conditions are highly prevalent among the geriatric and population suffering from other ailments, such as hypertension and cardiovascular diseases (CVDs) and diabetes, facilitating product adoption across developed and emerging nations.
  • According to Respirology, 1 billion of the world’s population of 7.3 billion people, between the ages of 30 and 69 years, has the most common Type of sleep-disordered breathing, obstructive sleep apnoea (OSA).
  • As a result of rising life anticipation, the growing geriatric population increases the prevalence of sleep disease. With the development of the geriatric population, the usage of Sleep apnea devices will increase, as the senior population is more prone to sleep apnea devices.
  • As per WHO (World Health Organization), in 2018, the world’s population of people aged 60 and above will reach 2.0 billion by 2050.
  • In 2021, the FDA announces the approval of a prescription tongue muscle stimulation device that claims to defeat mild obstructive sleep apnea (OSA) and to snore. The device, named eXciteOSA, is pass through the de novo regulatory pathway for people 18 years and older.


Worldwide Sleep Apnea Device Market Size was US$ 5.2 Billion in 2020

On the basis of Type, Sleep apnea appliances industry includes therapeutic devices and diagnostic devices. Sleep apnea therapeutic devices, such as Continuous Positive Airway Pressure (CPAP), Bilevel Positive Airway Pressure (BiPAP) and Auto CPAP Sleep Apnea machines. The (CPAP) continuous positive airway pressure unit is the most prescribed machine for sleep apnea. Auto CPAP Sleep Apnea machines are used to evaluate the patient’s respiratory and other bodily functions during sleep.


Apart from this, sleep apnea diagnostics devices are segmented into Polysomnography Devices (PSG), Respiratory Polygraph, Sleep Apnea Screening Devices, Oximeter, and Actigraphy Monitoring Device.  Pornographically Devices (PSG), attributed to the fact that it is a multi-parameter study that records patient’s brain waves, heart rate and breathing, the oxygen level in the blood, and even eye and leg movements during the diagnosis procedure.


Moreover, diagnostic devices, clinical PSG devices, pulse oximeters, and heart–rate systems make up most of the devices used in sleep hospitals and laboratories worldwide. The number of sleep tests performed and sleep laboratories with a clinical polysomnography device are increasing. These tests are promptly regarded as the regular diagnostic test for sleep apnea.


North America is Driving the Demand of Sleep Apnea Devices Industry

Among different regions, the increasing prevalence of respiratory illnesses in North America is causing sleeping disorders, boosting the demand for Sleep apnea devices. The United States operates the majority of the sleep apnea devices market in North America. According to the American Sleep Association, in 2018, 50-70 million adult populations in the United States were found to have a sleep disorder.


Furthermore, a huge patient pool, raising awareness of sleep apnea, and the presence of foreign manufacturers are boosting the demand for Sleep apnea devices in Europe. The abundance of diagnostic tests for proving the presence of sleep apnea in the region is fast increasing, as numerous people are concerned about the health concerns associated with this illness.


COVID-19 Pandemic Impact on Sleep Apnea Devices Market:

The COVID-19 pandemic affects the management of sleep apnea patients. Physical isolation, social distancing, and suspension of many clinical services complicate the already prevalent underdiagnosis of sleep disorders and potentially delay treatment for those diagnosed. Sleep Apnea Devices companies faced specific operational and logistic challenges due to the imposition of nationwide lockdowns.

Competitive Landscape:

The sleep apnea devices market is highly competitive, with several major players such as Summoned, Resmed, Koninklijke Philips N.V., Carefusion Corp. (Part of Becton, Dickinson and Company), Imthera Medical, Inc. (Part of Livanova Plc) across the world.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=sleep-apnea-devices-market-p.php


Market Summary

  • Type – Renub Research Report covered by Type in the Sleep Apnea Devices Market breakup by 2 viewpoints (Therapeutic Devices, Diagnostic Devices)
  • Therapeutic Devices – Sleep Apnea Devices Market have been further sub-segmented from 4 viewpoints: (CPAP Sleep Apnea, Auto CPAP Sleep Apnea, BiPAP Sleep Apnea, Others)
  • Diagnostic Devices – Sleep Apnea Devices Market have been further sub-segmented from 5 viewpoints: (Polysomnography Devices (PSG), Respiratory Polygraph, Sleep Apnea Screening Devices, Oximeter, and Actigraphy Monitoring Device)
  • End-User – Our Report covered by End User Sleep Apnea Devices Market breakup by 2 viewpoints (Sleep Laboratories & Hospitals & Home Care Setting/Individuals)
  • Region – This Report covered by Region Sleep Apnea Devices Market breakup by 4 viewpoints (North America, Europe, Asia Pacific, ROW)
  • All the major players have been covered from 3 Viewpoints (Overview, Recent Developments and Revenue) Summoned, Resmed, Koninklijke Philips N.V., Carefusion Corp. (Part of Becton, Dickinson and Company), Imthera Medical, Inc. (Part of Livanova Plc)

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Sleep Apnea Devices Market Will be US$ 8.7 Billion by 2027

Sleep apnea is a sleeping sickness that can be undoubtedly serious, wherein an individual’s breathing exhibits an irregular pattern. People with untreated sleep apnea encounter interrupted breathing in their sleep due to a shortage of oxygen dispense to the brain and the rest of the body parts. Today, sleep apnea is more common among elderly patients and people who are suffering from diabetes, hypertension, cardiovascular disorders. Further, to combat the condition named sleep apnea, the market has introduced equipment for managing sleeping apnea that facilitates breathing in patients suffering from sleep disorders. As per Renub Research Analysis, the Sleep Apnea Devices Market was valued at US$ 5.2 Billion in 2020.

sleep apnea devices market

The increasing prevalence of obesity and the rising geriatric population leads to a higher incidence of sleep apnea globally. The rise in incidence manifests a large patient pool requiring diagnosis and treatment for sleep apnea, driving the market’s growth. Ample provisions of undiagnosed patients, and government initiatives to promote diagnosis, are also expected to boost the demand for diagnostic devices and subsequently drive the market’s growth during the forecast period. Thereon, it is likely that the Sleep Apnea Machines Market is expected to expand at a CAGR of 7.63% from 2020 – 2027.

Restraints of Sleep Apnea Devices Market

Certain determinants like the high cost associated with devices restrict the market’s growth.
Similarly, in emerging countries like India, due to minimal medical coverage provided by public or private insurance companies, obstructs the development of the market in the region.
The lack of awareness concerning obstructive sleep apnea (OSA) in emerging countries is a vital factor expected to restrain the market’s growth during the forecast period.

Device Type

In terms of device type, the global Sleep Apnea market is segmented into therapeutic devices and diagnostic devices. In the therapeutic device segment, Positive Airway Pressure (PAP) devices are the most common devices used to treat sleep apnea. For healthcare providers globally, amongst the PAP devices, Continuous Positive Airway Pressure (CPAP) devices are the favoured choice of therapy for OSA. The high potency of CPAP and other PAP devices in treating sleep apnea has been conducive to increase the adoption of therapeutic devices globally.

However, the diagnostic device segment is awaited to grow firm due to a large pool of undiagnosed patients and raising awareness about available diagnostic and treatment options for sleep apnea among the general population, especially in emerging countries.

Sleep Laboratories & Hospitals, and Home Care Setting

The market is segmented into Sleep Laboratories & Hospitals, and Home Care Setting/Individuals based on end-user. The rising adoption of therapeutic devices like CPAP and oral appliances are attributed to the market expansion of the Home Care Setting/Individuals Market. In addition, the increasing prevalence of sleep apnea, along with adequate reimbursement policies by the government for patients residing in the Home Care Setting/Individuals Market, is another significant factor supporting a higher percentage of patients being treated in these facilities. Contrarily, Sleep Laboratories & Hospitals amidst the pandemic suffered a market setback due to fewer patients being treated due to the nationwide lockdown.

Regional Analysis of Sleep Apnea Devices

Among different regions, North America dominates the global sleep apnea devices market due to the higher prevalence of sleep apnea and favourable reimbursement policies, which has been pivotal in the higher adoption of sleep apnea devices in the region. Diversely, the market of Europe is expected to grow due to soaring awareness about sleep apnea and the increasing need for diagnostic tests coupled with the high adoption of sleep apnea devices in the region. The Asia-Pacific market is forecasted to grow faster due to the rising demand for devices in countries like Japan, Australia and the growing prevalence of sleep apnea in emerging countries.

Market Players Analysis

The sleep apnea devices market includes major players like CareFusion Corp. (Part of Becton, Dickinson and Company), Summoned, Resmed, Imthera Medical, Inc. (Part of Livanova Plc), Koninklijke Philips N.V.

Besides, a diverse and robust portfolio of these players, along with the focus on R&D to introduce new devices and solid geographical existence, are factors primarily attributing to the dominance of these players in the global market.

Additionally, the market players also emphasize the introduction of technically advanced devices that will increase compliance by offering extreme comfort to the patient. Thus, growing advances and innovations by market players are expected to increase the adoption of sleep apnea devices in the forecast period. Thereafter, in the coming years, as per our estimate, the Sleep Apnea Devices Market Size will increase across the world to reach US$ 8.7 Billion by 2027.

sleep apnea devices market size

COVID-19 Pandemic Impacts on this Industry

The outbreak of the COVID-19 pandemic has rigorously affected the management of sleep apnea patients worldwide. Several medical organizations like the European Respiratory Society and the American Academy of Sleep Medicine have recommended using telehealth and has provided guidelines to all sleep centres to postpone and reschedule the in-laboratory administration of PAP therapy and polysomnography, except in emergency cases.

For instance, as stated by the data published by the European Respiratory Journal, it has been observed that before a pandemic, laboratory-based PSG was performed regularly around 92.5% of centres. However, now this procedure is being performed only in 20% of centres of Europe.

Also, laboratory-based CPAP or bi-level therapy has been practised in numerous centres, but now less than one-fifth of these centres continued this routine. Thus, a reduction in these procedures among sleep centres can result in a decline in the diagnosis of new sleep apnea patients during the COVID-19 pandemic and can negatively impact the growth of the sleep apnea market in 2020.

Renub Research report titled “Sleep Apnea Devices Market, Global Forecast, by Types [Therapeutic (CPAP Sleep Apnea, Auto CPAP Sleep Apnea, BiPAP Sleep Apnea, Others), Diagnostics devices (Polysomnography Devices (PSG),Respiratory Polygraph, Sleep Apnea Screening Devices, Oximeter, Actigraphy Monitoring Device)], End Users (Sleep Laboratories & Hospitals & Home Care Setting/Individuals), Region (North America, Europe, Asia Pacific, Rest of the World), Company (Carefusion Corp, Somnomed, Resmed, Imthera Medical, Inc., Koninklijke Philips N.V.)” provides a detailed analysis of Worldwide Sleep Apnea Devices Industry.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=sleep-apnea-devices-market-p.php

Types – Sleep Apnea Devices Market breakup from 2 viewpoints:

  1. Therapeutic Devices
  2. Diagnostic Devices

Therapeutic Devices – Market have been further sub segmented from 4 viewpoints:

  1. CPAP Sleep Apnea Therapeutic Devices
  2. Auto CPAP Sleep Apnea Therapeutic Devices
  3. BiPAP Sleep Apnea Therapeutic Devices
  4. Others

Diagnostic Devices – Market have been further sub segmented from 5 viewpoints:

  1. Polysomnography Devices (PSG)
  2. Respiratory Polygraph
  3. Sleep Apnea Screening Devices
  4. Oximeter
  5. Actigraphy Monitoring Device

End User – Sleep Apnea Devices Market breakup from 2 viewpoints:

  1. Sleep Laboratories & Hospitals
  2. Home Care Setting/Individuals

global sleep apnea devices marke

Region – Sleep Apnea Devices Market breakup from 4 Regions:

  1. North America
  2. Europe
  3. Asia Pacific
  4. Rest of the World

All key players have been covered from 4 viewpoints:

• Overview
• Recent Developments
• Financial Insight

Company Analysis:

  1. Carefusion Corp. (Part Of Becton, Dickinson And Company)
  2. Somnomed
  3. Resmed
  4. Imthera Medical, Inc. (Part Of Livanova Plc)
  5. Koninklijke Philips N.V.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building and Construction, & Agriculture. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Our core team is comprised of experienced people holding graduate, postgraduate and PhD degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:
Renub Research
Phone No: +1 678–302–0700 (USA) | +91–120–421–9822 (IND)
Email: info@renub.com
Web: https://www.renub.com
Follow on Linkedin: https://www.linkedin.com/company/renub-research